Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-010503

Chief Legal Officer acquired 5,720 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robertson Jenny Chief Legal Officer 2025-03-14 Grant or award +5,720 $2.61 $14,929 63,619 D
Loading xslF345X05/form4-04092025_090405.xml…